Insider trading

Period: 120 months Stock: JNJ Plan: Not stated × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

46 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

46 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

46 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

46 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
46 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
46 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

46 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
6 Mar 2023
Swanson James D. See Remarks
Sold, plan not stated
$164.20K 1,062 at 154.66
10.3%
13 Dec 2022
Wolk Joseph J Exec VP, CFO
Sold, plan not stated 2×
$2.65M 14,781 at 179.60
29.2%
30 Nov 2022
McEvoy Ashley EVP, WW Chair, MedTech
Sold, plan not stated 2×
$12.87M 73,323 at 175.47
63.7%
Sold half or more
22 Nov 2022
Taubert Jennifer L EVP, WW Chair, Pharmaceuticals
Sold, plan not stated
$13.60M 76,923 at 176.78
37.8%
18 Nov 2022
Decker Robert J Controller, CAO
Sold, plan not stated
$2.96M 16,928 at 175.00
52.2%
Sold half or more
9 Nov 2022
Wengel Kathryn E EVP, Chief GSC Officer
Sold, plan not stated
$2.85M 16,410 at 173.42
18.7%
4 Nov 2022
Mongon Thibaut Exec VP, WW Chair, Consumer
Sold, plan not stated 2×
$6.03M 35,246 at 171.18
46.8%
24 Oct 2022
Fasolo Peter Exec VP, Chief HR Officer
Sold, plan not stated 174×
$13.44M 78,458 at 171.25
40.6%
24 Oct 2022
Hait William See Remarks
Sold, plan not stated 2×
$2.57M 15,000 at 171.55
15.8%
19 Oct 2022
Fasolo Peter Exec VP, Chief HR Officer
Sold, plan not stated 103×
$11.54M 70,126 at 164.50
37.9%
10 Jun 2022
Wengel Kathryn E EVP, Chief GSC Officer
Sold, plan not stated 4×
$6.92M 40,000 at 173.00
35.9%
26 May 2022
Decker Robert J Controller, CAO
Sold, plan not stated
$1.52M 8,462 at 180.00
35.4%
21 Apr 2022
Hait William See Remarks
Sold, plan not stated 8×
$5.45M 29,699 at 183.58
27.0%
17 Mar 2022
Mongon Thibaut Exec VP, WW Chair, Consumer
Sold, plan not stated 37×
$6.09M 34,555 at 176.25
46.3%
15 Mar 2022
Decker Robert J Controller, CAO
Sold, plan not stated 3×
$877.53K 5,000 at 175.51
24.4%
7 Dec 2021
Decker Robert J Controller, CAO
Sold, plan not stated
$816.05K 5,000 at 163.21
26.0%
9 Dec 2020
Sneed Michael E EVP, Global Corp Aff & COO
Sold, plan not stated
$8.36M 54,662 at 152.93
49.4%
2 Sep 2020
Wengel Kathryn E EVP, Chief GSC Officer
Sold, plan not stated 2×
$2.47M 16,115 at 153.52
21.6%
28 Jul 2020
McEvoy Ashley EVP, WW Chair, Medical Devices
Sold, plan not stated
$4.28M 29,000 at 147.47
57.2%
Sold half or more
13 Mar 2020
PEREZ WILLIAM D Director
Bought
$63.84K 500 at 127.69
3.2%
First buy on file
21 Feb 2020
Mongon Thibaut Exec VP, WW Chair, Consumer
Sold, plan not stated
$5.80M 39,224 at 147.96
52.3%
Sold half or more
30 Jan 2020
Sneed Michael E EVP, Global Corp Aff & COO
Sold, plan not stated
$8.68M 58,128 at 149.39
54.1%
Sold half or more
13 Dec 2019
Joly Hubert Director
Bought
$706.40K 5,000 at 141.28
opened
First buy on file
12 Dec 2019
Wengel Kathryn E EVP, Chief GSC Officer
Sold, plan not stated
$284.54K 2,017 at 141.07
3.9%
11 Jun 2019
Bought
$419.04K 3,000 at 139.68
opened
First buy on file
14 Dec 2018
PRINCE CHARLES Director
Bought
$268.73K 2,000 at 134.37
7.5%
First buy on file
14 Dec 2018
PEREZ WILLIAM D Director
Bought
$133.91K 1,000 at 133.91
12.3%
First buy on file
14 Dec 2018
MULCAHY ANNE M Director
Bought
$100.05K 748 at 133.76
12.9%
First buy on file
13 Dec 2018
Kapusta Ronald A Controller, CAO
Sold, plan not stated
$536.64K 3,643 at 147.31
21.1%
4 Dec 2018
Fasolo Peter Exec VP, Chief HR Officer
Sold, plan not stated
$6.10M 41,563 at 146.68
34.7%
3 Dec 2018
Fasolo Peter Exec VP, Chief HR Officer
Sold, plan not stated
$18.31M 125,132 at 146.32
61.5%
Sold half or more
23 Nov 2018
Sneed Michael E EVP, Global Corp Aff & COO
Sold, plan not stated
$4.41M 30,943 at 142.46
43.7%
16 Nov 2018
Gorsky Alex Chairman, CEO
Sold, plan not stated
$38.60M 264,465 at 145.96
44.0%
8 Nov 2018
Kapusta Ronald A Controller, CAO
Sold, plan not stated
$1.23M 8,441 at 145.15
32.8%
7 Nov 2018
Duato Joaquin Vice Chair, Exec Committee
Sold, plan not stated
$5.77M 40,000 at 144.36
30.0%
7 Sep 2018
Kapusta Ronald A Controller, CAO
Sold, plan not stated
$1.08M 7,899 at 137.18
23.5%
27 Aug 2018
Sneed Michael E EVP, Global Corp Aff & COO
Sold, plan not stated
$3.91M 29,000 at 134.80
49.0%
15 Feb 2018
Stoffels Paulus Exec VP, Chief Scientific Off
Sold, plan not stated
$20.17M 155,342 at 129.86
43.4%
24 Jul 2017
Stoffels Paulus Exec VP, Chief Scientific Off
Sold, plan not stated
$13.67M 102,692 at 133.14
44.6%
20 Jul 2017
Caruso Dominic J Exec VP, Finance; CFO
Sold, plan not stated
$11.29M 82,591 at 136.72
36.4%
3 Mar 2017
Duato Joaquin Exec VP, WW Chair, Pharma
Sold, plan not stated
$6.18M 50,000 at 123.62
42.2%
28 Feb 2017
Pruden Gary J Exec VP, WW Chair, Med Devices
Sold, plan not stated
$1.99M 16,299 at 122.21
27.2%
28 Feb 2017
Kapusta Ronald A Controller, CAO
Sold, plan not stated
$1.78M 14,543 at 122.26
32.7%
15 Feb 2017
Stoffels Paulus Exec VP, Chief Scientific Off
Sold, plan not stated
$2.58M 22,000 at 117.29
14.7%
1 Feb 2017
Ullmann Michael H Exec VP, General Counsel
Sold, plan not stated
$2.45M 21,735 at 112.88
18.2%
21 Oct 2016
PRINCE CHARLES Director
Bought
$99.85K 875 at 114.11
3.4%
First buy on file
Showing 1–46 of 46.